Meier, A., Reiche, D., de Laat, M., Pollitt, C., Walsh, D., & Sillence, M. (2018). The sodium-glucose co-transporter 2 inhibitor velagliflozin reduces hyperinsulinemia and prevents laminitis in insulin-dysregulated ponies. PLoS One.

Meier, Alexandra, Dania Reiche, Melody de Laat, Christopher Pollitt, Donald Walsh, e Martin Sillence. "The Sodium-glucose Co-transporter 2 Inhibitor Velagliflozin Reduces Hyperinsulinemia and Prevents Laminitis in Insulin-dysregulated Ponies." PLoS One 2018.

Meier, Alexandra, et al. "The Sodium-glucose Co-transporter 2 Inhibitor Velagliflozin Reduces Hyperinsulinemia and Prevents Laminitis in Insulin-dysregulated Ponies." PLoS One 2018.